dr. H.H. (Herma) Fidder

dr. H.H. (Herma) Fidder

Assistant Professor - medical
  • Gastroenterology and Hepatology

Research Output (121)

Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease:a cross-sectional study

van de Meeberg M. M., Seinen M. L., Fidder H. H., Lin M., Oldenburg B., de Boer N. K., Bouma G., de Jonge R., Bulatović Ćalasan M., 30 Jul 2022, In: BMC Gastroenterology. 22

Letter:loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply

Mahmoud Remi, Schultheiss Johannes P.D., Fidder Herma H., Oldenburg Bas Feb 2022, In: Alimentary Pharmacology and Therapeutics. 55 , p. 499-500 2 p.

Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease

Mahmoud Remi, Schultheiss Hans-Paul, Louwers Jonas, van der Kaaij M T, van Hellemondt B P, Mahmmod N, van Boeckel P G, Jharap B, Fidder Herma, Oldenburg Bas 28 Jan 2022, In: Clinical Gastroenterology and Hepatology. 20 , p. 2577-2587.e6

A Systematic Review with Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease:What Can We Learn from Randomized and Nonrandomized Studies?

Doeve Benthe H., Van De Meeberg Maartje M., Van Schaik Fiona D.M., Fidder Herma H. 1 Oct 2021, In: Journal of Clinical Gastroenterology. 55 , p. 798-809 12 p.

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

De Bock Ellen, Filipe Mando D., Meij Vincent, Oldenburg Bas, Van Schaik Fiona D.M., Bastian Okan W., Fidder Herma F., Vriens Menno R., Richir Milan C. 2 Jul 2021, In: BMJ Open Gastroenterology. 8

Art in Endoscopy:Dinosaur birth?

Fidder Herma H. 1 Jun 2021, In: Endoscopy. 53 , p. 569 1 p.

Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container

Schultheiss Johannes P.D., Altena Sandra, Clevers Max R., Baas Dominique, Jharap Bindia, Fidder Herma H. May 2021, In: Digestive Diseases and Sciences. 66 , p. 1477-1487 11 p.

Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease

Mahmmod Shaden, Schultheiss Johannes P D, van Bodegraven Ad A, Dijkstra Gerard, Gilissen Lennard P L, Hoentjen Frank, Lutgens Maurice W M D, Mahmmod Nofel, van der Meulen-de Jong Andrea E, Smits Lisa J T, Tan Adriaan C I T L, Oldenburg Bas, Fidder Herma H 4 Feb 2021, In: Inflammatory bowel diseases. 27 , p. 1954-1962 9 p.

Loss of response to anti-TNF alpha agents depends on treatment duration in patients with inflammatory bowel disease

Schultheiss Johannes P D, Mahmoud Remi, Louwers Jonas M, van der Kaaij Michiel T, van Hellemondt Boris P, van Boeckel Petra G, Mahmmod Nofel, Jharap Bindia, Fidder Herma H, Oldenburg Bas 2021, In: Alimentary Pharmacology & Therapeutics. 54 , p. 1298-1308 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet